Follow up after liver cancer treatment

You usually have follow up appointments to check how you are and see whether you have any problems or worries. The appointments also give you the chance to raise any concerns you have about your progress.

What happens?

Your doctor or nurse examines you at each appointment. They ask how you are feeling, whether you have had any symptoms or side effects, and if you are worried about anything. You might also have tests at some visits.

You'll probably have a blood test for the marker AFP at every visit if you had hepatocellular carcinoma (HCC) Open a glossary item. You may also have blood tests to check how well your liver is working (liver function tests). Other tests may include:

  • CT scans
  • ultrasound scans
  • MRI scans 
  • x-rays

You won't have all these tests at every visit. Your doctor might arrange scans if you have a new symptom or if there's something specific that needs checking. 

How often do you have check ups?

Follow up appointments might not be the same for everyone. How often you see your specialist depends on:

  • how you are feeling
  • the type of treatment you have had

Your healthcare team will discuss with you how often they want to see you.

Between appointments

Contact your doctor or specialist nurse if you have any concerns between appointments. You should also contact them if you notice any new symptoms. You don’t have to wait until your next visit.

Coping

Many people find their check ups quite worrying. A hospital appointment can bring back any anxiety you had about your cancer. It can help to tell someone close to you how you’re feeling. Sharing your worries can mean they don’t seem so overwhelming. Many people find it helpful to have counselling after cancer treatment.

You can also find people to share experiences with by using our online forum, Cancer Chat.

  • British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
    A Suddle and others
    Gut, 2024. Volume 0. Pages 1-34

  • Upper Gastro-Intestinal (UGI) and Hepato-Pancreato Biliary (HPB) cancer network clinical advisory group: Clinical guidelines
    Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Services, 2019

  • Greater Manchester and Cheshire HPB unit guidelines for the assessment and management of hepatobiliary and pancreatic disease
    Central Manchester University Hospitals NHS Foundation Trust, 2021

  • EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
    European Association for the Study of the Liver
    Journal of Hepatology, 2025. Volume 82. Pages 314-374

  • Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow up
    A Vogel and others
    Annals of Oncology, 2025

Last reviewed: 
26 Mar 2025
Next review due: 
27 Mar 2028

Related links